| FRANKLIN BIOTECHNOLOGY DISCOVERY A (ACC) USD | RVI BIOTECNOLOGÍA | 74,94% | 98,88% | 70,35% | 147,89% |
| GSQUARTIX MODIFIED STRATEGY ON THE BLOOMBERG COMMODITY INDEX TOTAL RETURN PORTFOLIO C (GBP HEDGED) | RVI MATERIAS PRIMAS | 35,03% | 45,28% | 70,33% | 53,03% |
| GOLDMAN SACHS NORTH AMERICA ENHANCED INDEX SUSTAINABLE EQUITY R CAP USD | RVI USA | 20,65% | 60,01% | 70,32% | · |
| GOLDMAN SACHS US CORE EQUITY PORTFOLIO BASE (CLOSE) USD DIS | RVI USA | 18,60% | 59,30% | 70,31% | 232,29% |
| AB SICAV I-GLOBAL VALUE PORTFOLIO S1 USD | RVI GLOBAL VALOR | 29,37% | 63,94% | 70,30% | 154,47% |
| FRANKLIN BIOTECHNOLOGY DISCOVERY A (ACC) HKD | RVI BIOTECNOLOGÍA | 74,86% | 98,87% | 70,30% | 147,72% |
| GOLDMAN SACHS US CORE EQUITY PORTFOLIO U (CLOSE) USD DIS | RVI USA | 18,57% | 59,30% | 70,30% | 232,43% |
| GOLDMAN SACHS US CORE EQUITY PORTFOLIO BASE (CLOSE) USD CAP | RVI USA | 18,59% | 59,31% | 70,29% | 232,85% |
| ISHARES EDGE MSCI USA QUALITY FACTOR UCITS ETF USD (ACC) | RVI USA | 20,43% | 56,92% | 70,29% | · |
| ALKEN FUND - ABSOLUTE RETURN EUROPE GB1 | RENT. ABSOLUTA. | 5,61% | 51,59% | 70,28% | 99,83% |
